Inventor
TEMPLE KAYLA J
US13 patents
Patents
13 patentsUS11820757B2Nov 21, 2023
Antagonists of the muscarinic acetylcholine receptor M4
UNIV VANDERBILT5 citations84
US11299481B2Apr 12, 2022
Antagonists of the muscarinic acetylcholine receptor M4
UNIV VANDERBILT5 citations83
US11352344B2Jun 7, 2022
Antagonists of the muscarinic acetylcholine receptor M4
UNIV VANDERBILT4 citations73
US11225484B2Jan 18, 2022
Substituted octahydropyrrolo[3,4-b]pyrroles as antagonists of the muscarinic acetylcholine receptor M4
UNIV VANDERBILT4 citations73
US11884676B2Jan 30, 2024
Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the muscarinic acetylcholine receptor M4
UNIV VANDERBILT4 citations72
US12577234B2Mar 17, 2026
Antagonists of the muscarinic acetylcholine receptor M4
UNIV VANDERBILT0 citations61
US12331055B2Jun 17, 2025
Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the muscarinic acetylcholine receptor M4
UNIV VANDERBILT0 citations60
US12552790B2Feb 17, 2026
Positive modulators of the muscarinic acetylcholine receptor M4
UNIV VANDERBILT0 citations59
US12448380B2Oct 21, 2025
Positive modulators of the muscarinic acetylcholine receptor M4
UNIV VANDERBILT0 citations59
US12344608B2Jul 1, 2025
Positive modulators of the muscarinic acetylcholine receptor M4
UNIV VANDERBILT0 citations59
US12139498B1Nov 12, 2024
Positive allosteric modulators of the muscarinic acetylcholine receptor M4
UNIV VANDERBILT0 citations49
US9572794B2Feb 21, 2017
Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists
UNIV VANDERBILT1 citations43
US9963466B2May 8, 2018
Substituted 5-membered heterocyclic analogs as protease activated receptor 4 (PAR-4) antagonists
UNIV VANDERBILT0 citations37